Lumbar Spinal Stenosis Clinical Trial
Official title:
Effect of Limaprost in Combination With Transforaminal Epidural Steroid Injection for the Treatment of Lumbar Spinal Stenosis: a Prospective, Double-blind, Randomized Controlled Trial
The purpose of this study was to compare the effects of limaprost(Opalmon® ) on walking ability, low back pain and leg pain after transforaminal epidural steroid injection (TFESI) was administered compared to the placebo group.
This study is a prospective, randomized, comparative clinical study that is assigned to a placebo group or a trial group before transforaminal epidural steroid injection (TFESI) is performed. The subjects of the study will receive an explanation of the study and decide to participate voluntarily in patients who have decided to undergo TFESI for neurogenic claudication and low back pain or leg pain due to lumbar spinal canal stenosis (LSS). All study subjects are presented with TFESI at the level appropriate for their symptoms in the operating room and then returned to the recovery room. All participants will be monitored for non-invasive blood pressure, electrocardiography, heart rate, and peripheral oxyven saturation during and after the procedure. Patients assigned to the placebo group will take placebo three times a day and one tablet once from the first day after receiving TFESI. Patients assigned to the trial group will take limaprost (Opalmon®) three times a day, one tablet once from the first day after receiving TFESI. In both groups, the drug was administered for 12 weeks. In both groups, during the first 4 weeks, no drug changes or additional procedures were observed, and only Acetaminophen was allowed as a rescue drug. After TFESI, visits at 4 weeks, 8 weeks and 12 weeks to collect each measurement variable. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04795284 -
Biomechanical Parameters of Gait in Patients With Symptomatic Lumbar Spinal Stenosis and Healthy Elderly.
|
||
Recruiting |
NCT04066296 -
Outcomes for Lumbar Decompressions With Use of Liposomal Bupivicaine
|
Phase 2 | |
Active, not recruiting |
NCT05114135 -
TLIF Osteo3 ZP Putty Study (Also Known as the TOP Fusion Study)
|
N/A | |
Recruiting |
NCT06075862 -
Balance Amongst Patients With Lumbar Spinal Stenosis
|
||
Recruiting |
NCT06057428 -
Activity Levels Amongst Patients With Lumbar Spinal Stenosis
|
||
Recruiting |
NCT05527145 -
Spinal Stenosis and Listhesis Treated With Percutaneous Interspinous Spacer: a Non-surgical Trial
|
N/A | |
Recruiting |
NCT01902979 -
The Spinal Stenosis Pedometer and Nutrition e-Health Lifestyle Intervention (SSPANLI) Trial
|
N/A | |
Completed |
NCT00749073 -
The Vertos MILD™ Preliminary Patient Evaluation Study
|
N/A | |
Completed |
NCT00527527 -
Chiropractic Dosage for Lumbar Stenosis
|
Phase 2 | |
Completed |
NCT00405691 -
Safety and Effectiveness Study of the TOPS System, a Total Posterior Arthroplasty Implant Designed to Alleviate Pain Resulting From Moderate to Severe Lumbar Stenosis
|
Phase 3 | |
Completed |
NCT03194607 -
Quantitative Evaluation of Motor Function Before and After Surgery for Degenerative Lumbar Spinal Stenosis
|
||
Recruiting |
NCT06034405 -
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
|
||
Completed |
NCT06079580 -
Patients With Lumbar Spinal Stenosis With Balance Disorder
|
||
Recruiting |
NCT05523388 -
Role of Spinal Load in the Pathophysiology of Lumbar Spinal Stenosis
|
||
Completed |
NCT04587401 -
The Effects of Anesthesia on Cerebral Perfusion in Patients With High Blood Pressure
|
N/A | |
Completed |
NCT04563793 -
Postmarket Outcomes Study for Evaluation of the Superion™ Spacer
|
||
Suspended |
NCT03381677 -
Pedicle Osteotomy for Stenosis Trial
|
N/A | |
Completed |
NCT02258672 -
Preoperative Rehabilitation for Patients Undergoing Surgery for Lumbar Spinal Stenosis
|
N/A | |
Completed |
NCT02260401 -
Long Term Outcomes of Lumbar Epidural Steroid Injections for Spinal Stenosis
|
N/A | |
Completed |
NCT01994512 -
Swedish Spinal Stenosis Study
|
N/A |